Organizing Committee
Principal Investigator, The Guccione Lab
Icahn School of Medicine at Mount Sinai, USA
Head of The Hadassah Cancer Research Institute (HCRI)
Hadassah Hebrew University Medical Center, Jerusalem, Israel
Head, Dermatology, Director of the Adaptive Resistance Team
Gustave Roussy and Paris Saclay University, France
Principal Investigator
Catholic University of the Sacred Heart, School of Medicine, Italy
Speakers
Oxana Beskrovnaya
Chief Innovation Officer
Dyne Therapeutics, USA
Honorary Consultant in Medical Oncology
University of Cambridge, UK, Lautenberg Center, Faculty of Medicine, The Hebrew University of Jerusalem, Israel
Christine Duthoit
CEO - CSO
RNAlead, France
Principal Investigator, The Guccione Lab
Icahn School of Medicine at Mount Sinai, USA
Head of The Hadassah Cancer Research Institute (HCRI)
Hadassah Hebrew University Medical Center, Jerusalem, Israel
François-Thomas Michaud
CEO
Feldan Therapeutics, Canada
Min Wen Ku
Application Scientist
VectorBuilder, UK
Amir Mor
CSO
RNAble, Israel
Head, Dermatology, Director of the Adaptive Resistance Team
Gustave Roussy and Paris Saclay University, France
Shai Rosenberg
Head of the Computational Medicine Service
Hadassah Hebrew University Medical Center, Jerusalem, Israel
Principal Investigator
Catholic University of the Sacred Heart, School of Medicine, Italy
Head of Research, RNA Splicing and Disease Lab
University of Southern Denmark
Peter D. Weinstein
CEO/General Counsel
Emervax, Inc., USA
